Clustering data with hclust algorithm for Role of medium in bacterial growth (Study ST000317)

Reversed phase POSITIVE ION MODE (Analysis AN000503)
MetaboliteStructureF1F2
DG (34:1)ME1138370.871.06
DG (34:2)ME1138380.731.10
DG (36:2)ME1138391.140.95
PC (37:2)ME1138591.380.90
PC (p-40:5) or PC (o-40:6)ME1138711.430.92
PC (34:1)ME1138510.001.54
PC (36:2)ME1138570.001.54
LPC (18:1)ME1138430.031.35
PE (36:1)ME1138730.081.34
TG (54:5)ME1139220.071.42
SM (d34:1)ME1138780.011.45
TG (49:1)ME1138980.011.45
PC (34:2)ME1138520.001.64
TG (48:2)ME1138950.001.63
TG (54:2)ME1139190.001.63
TG (49:0)ME1138970.061.68
PE (p-38:4) or PE (o-38:5)ME1138750.051.69
Acylcarnitine C16:0ME1138310.051.69
PC (38:5)ME1138630.051.69
TG (50:2)ME1139030.001.73
TG (54:1)ME1139180.001.73
TG (54:3)ME1139200.011.72
TG (52:3)ME1139120.011.72
TG (52:2)ME1139110.011.72
TG (50:1)ME1139020.011.72
TG (46:1)ME1138900.011.72
PC (34:3)ME1138530.011.72
PC (36:1)ME1138560.011.72
TG (52:1)ME1139100.001.72
TG (48:1)ME1138940.001.72
TG (51:2)ME1139060.001.72
PC (32:0)ME1138470.031.70
TG (46:0)ME1138890.041.70
TG (54:4)ME1139210.021.72
PC (35:2)ME1138540.031.71
TG (52:4)ME1139130.021.71
PC (38:4)ME1138620.181.60
TG (50:0)ME1139010.221.57
TG (56:1)ME1139230.071.59
TG (48:0)ME1138930.141.62
PC (p-32:0) or PC (o-32:1)ME1138680.131.64
TG (52:0)ME1139090.121.64
TG (58:2)ME113925NA1.00
TG (56:6)ME113924NA1.00
TG (53:4)ME113917NA1.00
TG (53:3)ME113916NA1.00
TG (52:5)ME113914NA1.00
TG (51:4)ME113908NA1.00
TG (51:3)ME113907NA1.00
TG (50:4)ME113905NA1.00
TG (50:3)ME113904NA1.00
TG (49:3)ME113900NA1.00
TG (48:3)ME113896NA1.00
TG (46:3)ME113892NA1.00
TG (46:2)ME113891NA1.00
TG (44:2)ME113888NA1.00
TG (44:1)ME113887NA1.00
TG (42:1)ME113886NA1.00
SM (d42:2)ME113885NA1.00
SM (d42:1)ME113884NA1.00
SM (d41:1)ME113883NA1.00
SM (d40:2)ME113882NA1.00
SM (d40:1)ME113881NA1.00
SM (d36:1)ME113880NA1.00
SM (d34:2)ME113879NA1.00
SM (d33:1)ME113877NA1.00
SM (d32:1)ME113876NA1.00
PE (p-36:2) or PE (o-36:3)ME113874NA1.00
PC (p-40:6) or PC (o-40:7)ME113872NA1.00
PC (p-38:2) or PC (o-38:3)ME113870NA1.00
PC (p-34:1) or PC (o-34:2)ME113869NA1.00
PC (o-32:0)ME113867NA1.00
PC (40:6)ME113866NA1.00
PC (40:5)ME113865NA1.00
PC (40:4)ME113864NA1.00
PC (38:3)ME113861NA1.00
PC (38:2)ME113860NA1.00
PC (35:3)ME113855NA1.00
PC (32:2)ME113849NA1.00
LPC (p-18:0) or LPC (o-18:1)ME113846NA1.00
LPC (o-16:0)ME113845NA1.00
LPC (16:0)ME113840NA1.00
Ceramide (d42:1)ME113836NA1.00
Ceramide (d40:1)ME113835NA1.00
Ceramide (d18:1/23:0)ME113834NA1.00
Acylcarnitine C18:0ME113832NA1.00
Acylcarnitine C18:1ME113833NA1.00
LPC (18:0)ME1138420.101.25
PC (36:4)ME1138580.011.12
PC (32:1)ME1138480.011.18
TG (49:2)ME1138990.011.18
PC (33:1)ME1138500.041.18
TG (53:1)ME1139150.031.18
LPC (16:1)ME1138410.281.36
LPC (22:6)ME1138440.431.19

Factors:

F1Media type:A
F2Media type:E
Data matrix
  logo